Repeated immunotherapy using intratumoural injection with recombinant interleukin-2 and tumour-infiltrating lymphocytes inhibits growth of breast cancer and induces apoptosis of tumour cells

Cancer Letters

Volumn 103, Issue 2, 1996, Pages 131-136

  Liu, David L ^a,c   Yang, M Q ^b   Eberhardt, J ^c   Persson, B ^c  

^a Top Cancer Institute   (Sweden)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Apoptosis; Breast cancer; Cytokine; Immunohistology; Immunotherapy; Interleukin 2; Tumour infiltrating lymphocytes

Indexed keywords

RECOMBINANT INTERLEUKIN 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER IMMUNOTHERAPY; CANCER INHIBITION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; INTRATUMORAL DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; RAT; TUMOR ASSOCIATED LEUKOCYTE; TUMOR REJECTION; TUMOR VOLUME;

EID: 0030009332     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/0304-3835(96)04195-X     Document Type: Article

References (20)

1. Harris, J.R., Morrow, M. and Bondonna, G. (1993) Cancer of the breast. In: Cancer, Principles and Practice of Oncology. Editors: V.T. DeVita, S. Hellman and S.A. Rosenberg. J.B. Lippincott, Philadelphia, PA, p. 1264.
2. Keane, P., Sikora, K., Waxman, J. and Wood, C.B. (1990) Breast. In: Treatment of Cancer. Editors: K. Sikora and K.E. Halnan. Chapman and Hall., New York, p. 369.
3. Yuan, J.M., Wang, Q.S., Ross, R.K., Henderson, B.E. and Yu, M.C. (1995) Diet and breast cancer in Shanghai and Tianjin, China. Br. J. Cancer, 71, 1353-1358.
4. Rosenberg, S.A. (1990) Adoptive immunotherapy for cancer. Sci. Am., 262, 34-41.
5. Rosenberg, S.A. (1993) New approaches to cancer treatment. In: Cancer, Principles and Practice of Oncology. Editors: V.T. DeVita, S. Hellman and S.A. Rosenberg. J.B. Lippincott, Philadelphia, PA, p. 2598.
6. Liu, D.L. and Seifert, J. (1994) Immunotherapy in liver tumours: II. Triple immunotherapy with intratumoral injection with activated tumour-infiltrating lymphocytes, intrasplenic administration of rIL-2 and IFN-a causes remission and lysis of rat liver tumour. Cancer Lett., 85, 39-46.
7. Liu, D.L., Radnell, M., Svanberg, K. and Seifert, J. (1995) Immunotherapy in liver tumours: III. A new experimental model of metastatic liver tumours from colorectal carcinoma for cytokine therapy. Cancer Lett., 88, 211-219.
8. Liu, D.L. and Lefor, A.T. (1995) Repeated immunotherapy using a low dose of recombinant IL-2, large number of tumour-infiltrating lymphocytes for patients with metastatic liver tumours. Ann. Oncol., in press.
9. Mackensen, A., Ferradini, L., Carcelainm, G. and Triebel, F. (1993) Evidence for in situ amplification of cytotoxic T-lymphocytes with antitumor activity in a human regressive melanoma. Cancer Res., 53, 3569-3573.
10. Harada, M., Matsuzaki, G., Shinomiya, Y. and Kurosawa, S. (1994) Generation of tumour-specific cytotoxic T lymphocytes in vivo by combined treatment with inactivated tumour cells and recombinant interleukin-2. Cancer Immunol. Immunother., 38, 332-338.
11. Topalian, S.L., Muul, L.M., Solommon, D. and Rosenberg, S.A. (1987) Expansion of human tumour infiltrating lymphocytes for use in immunotherapy trials. J. Immunol. Methods, 102, 127-132.
12. Harris, R.A., Hiles, I.D., Page, M.J. and O'Hare, M.J. (1995) The induction of apoptosis in human mammary luminal epithelial cells by expression of activated c-neu and its abrogation by glucocorticoids. Br. J. Cancer, 72, 386-392.
13. Ormerod, M.G., O'nell, C.F., Robertson, D. and Harrap, K.R. (1994) Cisplatin induces apoptosis in a human ovarian carcinoma cell line without concomitant internucleosomal degradation of DNA. Exp. Cell Res., 211, 231-237.
14. Catchpoole, D.R. and Stewart, B.W. (1993) Etoposide-induced cytotoxicity in two human T-cell leukemic lines: delayed loss of membrane permeability rather than DNA fragmentation as an indicator of programmed cell death. Cancer Res., 53, 4287-4296.
15. Rosl, F. (1992) A simple and rapid method for the detection of apoptosis in human cells. Nucleic Acids Res., 20, 5243.
16. Abbas, A.K., Lightman, A.H. and Pober, J.S. (1994) Cellular and Molecular Immunology. W.B. Saunders, Philadelphia, PA, pp. 356-375.
17. Schendel, D.J. and Gansbacher, B. (1993) Tumour-specific lysis of human renal cell carcinomas by tumour-infiltrating lymphocytes: modulation of recognition through retroviral transduction of tumour cells with interleukin 2 complementary DNA and exogenous a interferon treatment. Cancer Res., 53, 4020-4025.
18. Alder, A., Stein, J.A., Kedar, E. et al. (1984) Intralesional injection of interleukin-2-expended autologous lymphocytes in melanoma and breast cancer patients: a pilot study. J. Biol. Response Mod., 3, 491-500.
19. Lotze, M.T., Matory, Y.L. and Ettinghausen, S.E. (1985) In vivo administration of purified human interleukin-2. II. Half-life, immunologic effects, and expansion of peripheral lymphoid cells in vivo with recombinant IL-2. J. Immunology, 135, 2865-2875.
20. Heys, S.D., Franks, C.R. and Eremin, O. (1993) Interleukin 2 therapy: current role in surgical oncological practice. Br. J. Surg., 80, 156-162.